INFLUENCE OF INGARON UPON IMMUNE STATE OF THE PATIENTS WITH ADENOCARCINOMA OF LUNG IN THE COURSE OF ADJUVANT THERAPY
This clinical trial included 63 patients with lung adenocarcinoma who underwent radical surgical resection of the tumor at the Thoracic Surgery Department of Rostov Research Oncological Institute from 2009 to 2011, The patients were randomized in two groups, i.e., 33 patients (52%) of the main group...
Main Authors: | S. P. Pyltsin, E. Yu. Zlatnik, Yu. N. Lazutin, G. Z. Sergostyants, G. I. Zakora, I. A. Leyman, P. A. Anistratov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2015-01-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/768 |
Similar Items
-
Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases
by: Yuri Nishioka, et al.
Published: (2023-10-01) -
Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
by: Victor Mortier, et al.
Published: (2022-12-01) -
Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma
by: Bo Li, et al.
Published: (2021-05-01) -
Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
by: Xiao Liu, et al.
Published: (2024-04-01) -
Locally advanced female urethral adenocarcinoma of enteric origin: The role of adjuvant chemoradiation and brief review
by: Ling-Ping Chen, et al.
Published: (2011-04-01)